about o2h group
Founded in 2005, o2h discovery is a Contract Research Organisation which has an integrated drug discovery platform operating from its state-of-the-art research centre in India and The Mill SciTech Park, Cambridge, UK.
We have the in-house capability to execute hit-lead-optimization programs leading into patent and IND filing from our state-of-the-art biotechnology incubator with expertise in discovery chemistry, biology, pharmacology, and the ongoing project management of pre-clinical development.
our culture
The DNA of o2h group is centred around the nurturing of its people, values and culture. It reflects in the way we work with each other, as well as our collaborators and partners.
Our set of values are centred around the speed at which we learn, innovation, teamwork, attention to detail, energy, delivery, integrity, and community.
innovation timeline
We are constantly innovating our people, technology and project management delivery models to deliver outstanding results for our collaborators.
2003
Transparency & reduced hierarchy.
2004
Live web feeds from discovery units. UK based project management.
2005
360 reviews to promote teamwork and enhance performance of employees.
2006
27 point productivity & turn around metrics.
2007
Pioneers of Insight Driven Communication.
More desk space for literature search. Equity into startups discovery companies.
2008
Incentives linked to collaborator satisfaction. Launched 'Fast Start' metrics.
2017
Launched discovery project management mobile app.
2018
Established ADME assay platform. Launched the o2h S/EIS Therapeutics fund.
2019
PR&D Scaleup up to 200L.
2020
Proprietary Fragment Library design and synthesis.
2021
Launched Biology labs in Cambridge, UK.
2022
New Research Facility in Ahmedabad, India, enabling capacity to expand 500 FTEs.
2023
Launched Kickstarter Competition to support early-stage biotech. Full service lab units.
show timeline
track record
We have a track record of delivering high quality integrated drug discovery services since 2005.
leadership team
Sunil Shah
CEO - o2h Ventures and Co-Founder - o2h discovery
Sunil's Biography
Sunil Shah
CEO - o2h Ventures and Co-Founder - o2h discovery
A serial entrepreneur having begun a career in the Life Sciences team at PA Consulting group followed by co-founding two companies in the information technology and life sciences sector. The second of these companies, Oxygen Healthcare Ltd was acquired by Piramal Enterprises Ltd (BSE: PEL). Sunil co-founded o2h ventures which involves discovery services / collaborations, seeding drug discovery, academic in-licensing and biotechnology incubation. Sunil has a degree in Biochemistry and an MBA from Cambridge University
Connect on linkedin
Prashant Shah
CEO - o2h discovery and Co-Founder - o2h group
Prashant's Biography
Prashant Shah
CEO - o2h discovery and Co-Founder - o2h group
Prashant is a serial entrepreneur in life sciences and tech in which one of those companies was acquired by a public company. He is currently active in seed investing (a portfolio of ~50 companies), product/IP development, services, and building lab/office infrastructure. The early career was with the Strategy group at Accenture. He has a BEng, an MSc, in which he worked on the Human Genome Program at the Sanger Centre, and an MPhil in Management from the Judge Institute. Prashant is also a General Partner in the o2h SEIS/EIS Human Health Funds.
Connect on linkedin
Andy Morley
Chief Scientific Officer
Andy's Biography
Andy Morley
Chief Scientific Officer
Andy is a highly experienced and accomplished Medicinal Chemist with over 25 years of experience in major pharmaceutical companies such as Sanofi-Aventis and AstraZeneca. He has extensive experience across all phases of drug discovery and has played a key role in the development of five candidates that have reached clinical trials. Andy is a prolific author and inventor, with over 55 publications and patents to his name. Since 2013, he has been working full-time with o2h Limited, where he leads the scientific evaluation of investment opportunities and provides scientific support. He has also served as CSO for two early-stage collaborations within the o2h Ventures portfolio, demonstrating his ability to successfully guide drug discovery projects from concept to clinical development.
Connect on linkedin
Nilesh Dagia
Chief Special Projects Officer
Nilesh's Biography
Nilesh Dagia
Chief Special Projects Officer
Nilesh leads the global operations of o2h group covering a wide range of innovation led investment, life-science and technology businesses. He is also overseeing the development and execution of the new o2h discovery Shirish Research Centre in Ahmedabad, India. Prior to joining o2h group, Nilesh worked with Piramal Group in various capacities including as an Alliance Manager for a risk-share oncology-based collaboration with a US Big Pharma and has also worked as the Head of Biology in Piramal Discovery solutions. Nilesh obtained his Ph.D. from Ohio University and completed a post-doc in Immunology, Stem Cells and Regenerative Medicine at Harvard Medical School. He is the author and inventor of >30 life science patents and publications. He received the Young Scientist of India award from OPPI in 2010.
Connect on linkedin